The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: omalizumab     Quarter: 2016Q3

Total Drug/Injury Combinations: 175     Number of Pages: 9

DRUGNAME PT EventCount
Omalizumab Maternal exposure during pregnancy 51 view events
Omalizumab Upper respiratory tract infection 40 view events
Omalizumab Anaphylactic reaction 38 view events
Omalizumab Asthma 34 view events
Omalizumab Pneumonia 33 view events
Omalizumab Nasopharyngitis 29 view events
Omalizumab Malaise 27 view events
Omalizumab Weight increased 25 view events
Omalizumab Headache 23 view events
Omalizumab Pyrexia 23 view events
Omalizumab Blood pressure decreased 22 view events
Omalizumab Migraine 19 view events
Omalizumab Oedema 19 view events
Omalizumab Pain in extremity 19 view events
Omalizumab Somnolence 19 view events
Omalizumab Urinary tract infection 19 view events
Omalizumab Acne 18 view events
Omalizumab Adverse drug reaction 18 view events
Omalizumab Asthenia 18 view events
Omalizumab Blood pressure increased 18 view events

Total Drug/Injury Combinations: 175     Number of Pages: 9

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)